BMRN: BioMarin Pharmaceutical Inc
BMRN exchange rate has changed by 1.57% for today. During the day, the instrument was traded at a low of 59.60 and at a high of 60.89.
Follow BioMarin Pharmaceutical Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BMRN News
- Amicus earnings on deck as $4.8B BioMarin deal awaits vote
- What to Expect From These Drug/Biotech Players This Earnings Season?
- BridgeBio Unveils Positive Results For Its Most 'Hotly Debated' Phase 3 Drug
- Baird maintains BioMarin stock rating amid competitor’s positive trial data
- PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
- BioMarin, Ascendis stocks fall after BridgeBio’s positive achondroplasia data
- Pharma companies left out of Trump’s drug-pricing deals look for way in
- Earnings Preview: BioMarin Pharmaceutical (BMRN) Q4 Earnings Expected to Decline
- Should Investors Buy, Sell or Hold Amicus Stock Ahead of Q4 Earnings?
- The Right Play On BioMarin Pharmaceuticals (NASDAQ:BMRN)
- BioMarin prices $850 million in senior notes to fund Amicus acquisition
- FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?
- BioMarin to offer $850 million in notes to fund Amicus acquisition
- Amicus Therapeutics CEO Campbell sells $1.07 million in shares
- Jefferies downgrades Amicus Therapeutics stock to Hold on acquisition outlook
- BioMarin stock rating upgraded by Canaccord Genuity on Amicus acquisition
- FOLD Rises 136% in 6 Months: Should You Buy, Sell or Hold the Stock?
- Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term
- Zacks.com featured highlights include Universal Health Services, PNC Financial Services, Global Payments and BioMarin Pharmaceutical
- Buy These 5 Price-to-Book Value Stocks for Gains in 2026
- Humana Partners With Atlas to Enhance Cancer Care for Seniors
- 4 Value Stocks to Buy As Wall Street Weighs Trump Policies
- BMRN or TARS: Which Is the Better Value Stock Right Now?
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
Frequently Asked Questions
What is BMRN stock price today?
BioMarin Pharmaceutical Inc stock is priced at 60.89 today. It trades within 59.60 - 60.89, yesterday's close was 59.95, and trading volume reached 1135. The live price chart of BMRN shows these updates.
Does BioMarin Pharmaceutical Inc stock pay dividends?
BioMarin Pharmaceutical Inc is currently valued at 60.89. Dividend policy depends on the company, while investors also watch -14.49% and USD. View the chart live to track BMRN movements.
How to buy BMRN stock?
You can buy BioMarin Pharmaceutical Inc shares at the current price of 60.89. Orders are usually placed near 60.89 or 61.19, while 1135 and 1.35% show market activity. Follow BMRN updates on the live chart today.
How to invest into BMRN stock?
Investing in BioMarin Pharmaceutical Inc involves considering the yearly range 50.76 - 73.51 and current price 60.89. Many compare 7.79% and 4.26% before placing orders at 60.89 or 61.19. Explore the BMRN price chart live with daily changes.
What are BioMarin Pharmaceutical Inc stock highest prices?
The highest price of BioMarin Pharmaceutical Inc in the past year was 73.51. Within 50.76 - 73.51, the stock fluctuated notably, and comparing with 59.95 helps spot resistance levels. Track BioMarin Pharmaceutical Inc performance using the live chart.
What are BioMarin Pharmaceutical Inc stock lowest prices?
The lowest price of BioMarin Pharmaceutical Inc (BMRN) over the year was 50.76. Comparing it with the current 60.89 and 50.76 - 73.51 shows potential long-term entry points. Watch BMRN moves on the chart live for more details.
When did BMRN stock split?
BioMarin Pharmaceutical Inc has gone through stock splits historically. These changes are visible in , 59.95, and -14.49% after corporate actions.
- Previous Close
- 59.95
- Open
- 60.08
- Bid
- 60.89
- Ask
- 61.19
- Low
- 59.60
- High
- 60.89
- Volume
- 1.135 K
- Daily Change
- 1.57%
- Month Change
- 7.79%
- 6 Months Change
- 4.26%
- Year Change
- -14.49%
- Act
- 1.322 M
- Fcst
- 1.333 M
- Prev
- 1.272 M
- Act
- 1.404 M
- Fcst
- 1.340 M
- Prev
- 1.322 M
- Act
- 1.388 M
- Fcst
- 1.372 M
- Prev
- 1.411 M
- Act
- 1.448 M
- Fcst
- 1.441 M
- Prev
- 1.388 M
- Act
- -1.4%
- Fcst
- -3.2%
- Prev
- 5.4%
- Act
- 0.9%
- Fcst
- 0.3%
- Prev
- 0.4%
- Act
- 3.9%
- Fcst
- -6.6%
- Prev
- -4.2%
- Act
- 6.2%
- Fcst
- -0.4%
- Prev
- 3.9%
- Act
- 0.7%
- Fcst
- 0.1%
- Prev
- 0.2%
- Act
- 2.3%
- Fcst
- 2.9%
- Prev
- 2.0%
- Act
- Fcst
- Prev
- Act
- 4.664%
- Fcst
- Prev
- 4.846%
- Act
- Fcst
- Prev
- Act
- Fcst
- $185.3 B
- Prev
- $220.2 B